Metraipolis › archive › dc_292ebdb7e602

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease — Europe PMC PMID:42643714

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42643714
DOI
10.3389/fneur.2026.1863897
License (as archived)
solo-consultazione
Archived
2026-10-08T09:55:29.672Z
SHA-256 of the archived text
2a66c40c11a329b51302874d317c3a01dd7e925c794f9e1d68b9d9546f41fc43
Stable URL of this page
https://metraipolis.com/documento/dc_292ebdb7e602

How to cite

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease — Europe PMC PMID:42643714 — Europe PMC (en), https://europepmc.org/article/MED/42643714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_292ebdb7e602 (Metraipolis archive dc_292ebdb7e602, sha256 2a66c40c11a329b51302874d317c3a01dd7e925c794f9e1d68b9d9546f41fc43)
BibTeX
@misc{dc292ebdb7e602,
  title = {Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease — Europe PMC PMID:42643714},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42643714},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_292ebdb7e602; sha256 2a66c40c11a329b51302874d317c3a01dd7e925c794f9e1d68b9d9546f41fc43},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42643714. Agents can read the archived copy with the MCP tool read_document.